VIR Competitors & Alternatives
Compare Vir Biotechnology Inc with similar stocks in the same industry
Biotechnology
VIR
Main Stock$12.27
Tradestie Score
53
Market Cap
$791.82M
Revenue Growth
195.8%
Analyst Upside
+83.4%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$28.18
|
$2.37B | 124.5 | 52 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$6.10
|
$2.34B | - | 40 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$83.17
|
$2.33B | - | 46 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$31.94
|
$2.33B | - | 44 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.40
|
$2.23B | - | 57 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.48
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$51.96
|
$2.21B | - | 57 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.24
|
$2.18B | - | 52 | Compare |
More VIR Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry